[HTML][HTML] The controversy over the efficacy of pneumococcal vaccine

R Andrews, SA Moberley - CMAJ, 2009 - Can Med Assoc
In this issue of CMAJ, Huss and colleagues 1 report the results of their meta-analysis of the
efficacy of pneumococcal polysaccharide vaccine in adults. By our reckoning, this is the …

Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials?

JD Clemens, ED Shapiro - Reviews of infectious diseases, 1984 - academic.oup.com
It has been more than five years since the relicensure of pneumococcal vaccine. There are
few data, however, with which to evaluate the efficacy of pneumococcal vaccine for the …

Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials

MJ Fine, MA Smith, CA Carson, F Meffe… - Archives of Internal …, 1994 - jamanetwork.com
Background: Because of the prevalence of pneumococcal pneumonia, the substantial
morbidity and mortality associated with many pneumococcal infections, and an increase in …

Efficacy of pneumococcal vaccination in adults: a meta-analysis

A Huss, P Scott, AE Stuck, C Trotter, M Egger - Cmaj, 2009 - Can Med Assoc
Background: Clinical trials and meta-analyses have produced conflicting results of the
efficacy of unconjugated pneumococcal polysaccharide vaccine in adults. We sought to …

Clinical effectiveness of pneumococcal vaccine. Meta-analysis.

BG Hutchison, AD Oxman, HS Shannon… - Canadian family …, 1999 - ncbi.nlm.nih.gov
OBJECTIVE: To determine the clinical effectiveness of pneumococcal vaccine. DATA
SOURCES: Computerized searches of MEDLINE, EMBASE, and SCISEARCH databases …

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence

DS Fedson - The Lancet Infectious Diseases, 2003 - thelancet.com
Punam Mangtani and colleagues review1 of the evidence on efficacy of pneumococcal
vaccine for adults who live in more developed countries focuses on ten prospective clinical …

151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries≥ 65 Years Old

T Pilishvili, OM Almendares, S Nanduri… - Open Forum …, 2018 - academic.oup.com
Background Pneumococcal conjugate vaccine (PCV13) was recommended in series with
PPSV23 for all US adults≥ 65 years in late 2014. We evaluated effectiveness of PCV13 …

Pneumococcal vaccination

A De Roux, H Lode - European Respiratory Journal, 2005 - Eur Respiratory Soc
It has been some time now since AUSTRIAN et al.[1] performed a vaccination trial evaluating
the effectiveness of a 15-valent pneumococcal polysaccharide vaccine (PPV) in South …

Belgian consensus on pneumococcal vaccine

P Bachcz, R Peleman, J Vanatoru… - Acta Clinica …, 1996 - Taylor & Francis
Streptococcus pneumoniae (pneumococcus) is the most common cause of community-
acquired pneumonia and a common cause of sepsis and meningitis. The incidence of these …

Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia

J Johnstone, DT Eurich, JK Minhas… - Clinical infectious …, 2010 - academic.oup.com
Background. There is debate surrounding the effectiveness of the 23-valent pneumococcal
polysaccharide vaccine (PPV). We determined whether PPV was associated with reduced …